UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma

Digestive and liver disease, 2023-04, Vol.55 (4), p.534-540

2023

Volltextzugriff (PDF)

Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes

Dalton transactions : an international journal of inorganic chemistry, 2018-11, Vol.47 (43), p.15477-15486

2018

Volltextzugriff (PDF)

Au()-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells

Dalton transactions : an international journal of inorganic chemistry, 2019-11, Vol.48 (42), p.1617-1625

2019

Volltextzugriff (PDF)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis

British journal of cancer, 2014-05, Vol.110 (11), p.2708-2715

2014

Volltextzugriff (PDF)

Occult Liver Disease Burden: Analysis from a Large General Practitioners Database

Journal of hepatology, 2016, Vol.64 (2), p.S456-S456

2016

Volltextzugriff (PDF)

Role of SerpinB3 in the stimulation of macrophage activation marker sCD163 in hepatitis C virus infected patients

Journal of hepatology, 2017, Vol.66 (1), p.S325-S325

2017

Volltextzugriff (PDF)

Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer

Journal of hepatology, 2017, Vol.66 (1), p.S536-S536

2017

Volltextzugriff (PDF)

Role of SerpinB3 in the stimulation of macrophage activation marker sCD163 in HCV infected patients

Digestive and liver disease, 2017-02, Vol.49 (1), p.e6-e6

2017

Volltextzugriff (PDF)

The Strategy of Fighting MYC Activity to Hinder Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S560-S560

2016

Volltextzugriff (PDF)

Functionalized polymers to target SerpinB3 in hepatoma cells

Digestive and liver disease, 2016-02, Vol.48, p.e45-e45

2016

Volltextzugriff (PDF)

Squamous cell carcinoma antigen in human liver carcinogenesis

Journal of clinical pathology, 2008-04, Vol.61 (4), p.445-447

2008

Volltextzugriff (PDF)

HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients

Journal of viral hepatitis, 2015-10, Vol.22 (10), p.800-808

2015

Volltextzugriff (PDF)

FRI0245 SCCA-IGM Is Up-Regulated in Scleroderma Patients with Reduced DLCO: A New Biomarker of Pulmonary Involvement?

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.522-522

2016

Volltextzugriff (PDF)

In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapy

Journal of hepatology, 2017, Vol.66 (1), p.S212-S212

2017

Volltextzugriff (PDF)

Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies

Biomaterials, 2005-12, Vol.26 (34), p.7038-7045

2005

Volltextzugriff (PDF)

The Protease-Inhibitor SERPINB3 Activates Canonical WNT Pathway in Monocytes

Journal of hepatology, 2016, Vol.64 (2), p.S556-S557

2016

Volltextzugriff (PDF)

The immunomodulatory activity of the protease-inhibitor SerpinB3 in vivo and in vitro

Journal of hepatology, 2017, Vol.66 (1), p.S163-S164

2017

Volltextzugriff (PDF)

Oncostatin M induces increased invasiveness and angiogenesis in hepatic cancer cells through HIF1alpha-related release of VEGF-A

Journal of hepatology, 2017, Vol.66 (1), p.S634-S634

2017

Volltextzugriff (PDF)

MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma

Digestive and liver disease, 2017-02, Vol.49 (1), p.e28-e28

2017

Volltextzugriff (PDF)

Serpinb3 Up-Regulates Hypoxia Inducible Factors-1alpha and -2alpha in Liver Cancer Cells through Different Mechanisms

Journal of hepatology, 2016, Vol.64 (2), p.S579-S580

2016

Volltextzugriff (PDF)

Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming

Journal of hepatology, 2016, Vol.64 (2), p.S563-S563

2016

Volltextzugriff (PDF)

In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy

Digestive and liver disease, 2017-02, Vol.49 (1), p.e48-e49

2017

Volltextzugriff (PDF)

P1260 IRON-DEPENDENT REGULATION OF SERPINB3

Journal of hepatology, 2014-04, Vol.60 (1), p.S509-S509

2014

Volltextzugriff (PDF)

P32 HYPERDYNAMIC CIRCULATORY SYNDROME IN A MOUSE MODEL TRANSGENIC FOR LIVER SERPINB3

Journal of hepatology, 2014-04, Vol.60 (1), p.S77-S77

2014

Volltextzugriff (PDF)

The protease-inhibitor SerpinB3 modulate survival and Wnt pathway of inflammatory human monocytes

Digestive and liver disease, 2016-02, Vol.48, p.e27-e27

2016

Volltextzugriff (PDF)

1 – 25 von 372

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(325)

Publikationsform

Sprache

Englisch
(368)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bile detection of squamous cell carcinoma antigen (SCCA) in extrahepatic cholangiocarcinoma

Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes

Au()-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis

Occult Liver Disease Burden: Analysis from a Large General Practitioners Database

Role of SerpinB3 in the stimulation of macrophage activation marker sCD163 in hepatitis C virus infected patients

Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer

Role of SerpinB3 in the stimulation of macrophage activation marker sCD163 in HCV infected patients

The Strategy of Fighting MYC Activity to Hinder Hepatocellular Carcinoma

Functionalized polymers to target SerpinB3 in hepatoma cells

Squamous cell carcinoma antigen in human liver carcinogenesis

HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients

FRI0245 SCCA-IGM Is Up-Regulated in Scleroderma Patients with Reduced DLCO: A New Biomarker of Pulmonary Involvement?

In hepatitis C infected patients with cirrhosis squamous cell carcinoma antigen (SCCA)-IgM levels may contribute to identify the individual risk of hepatocellular carcinoma development after antiviral therapy

Extracellular matrix-enriched polymeric scaffolds as a substrate for hepatocyte cultures: in vitro and in vivo studies

The Protease-Inhibitor SERPINB3 Activates Canonical WNT Pathway in Monocytes

The immunomodulatory activity of the protease-inhibitor SerpinB3 in vivo and in vitro

Oncostatin M induces increased invasiveness and angiogenesis in hepatic cancer cells through HIF1alpha-related release of VEGF-A

MiR-122 targets SerpinB3 and is involved in Sorafenib resistance in hepatocellular carcinoma

Serpinb3 Up-Regulates Hypoxia Inducible Factors-1alpha and -2alpha in Liver Cancer Cells through Different Mechanisms

Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming

In HCV infected patients with cirrhosis Squamous Cell Carcinoma Antigen (SCCA)-IgM levels may contribute to identify the individual risk of HCC development after antiviral therapy

P1260 IRON-DEPENDENT REGULATION OF SERPINB3

P32 HYPERDYNAMIC CIRCULATORY SYNDROME IN A MOUSE MODEL TRANSGENIC FOR LIVER SERPINB3

The protease-inhibitor SerpinB3 modulate survival and Wnt pathway of inflammatory human monocytes

Suchergebnisse filtern